Skip to main content
Erschienen in: Pathology & Oncology Research 2/2016

01.04.2016 | Original Article

Chemokine Expression Profiles of Human Hepatoma Cell Lines Mediated by Hepatitis B Virus X Protein

verfasst von: Di-Yi Wang, Li-Ping Zou, Xiao-Jia Liu, Hong-Guang Zhu, Rong Zhu

Erschienen in: Pathology & Oncology Research | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

The hepatitis B virus X protein (HBx), which is encoded by hepatitis B virus (HBV), plays crucial roles in the tumorigenesis of HBV associated hepatocellular carcinoma (HCC). Recent studies suggest that the HBx is involved in regulation of host immune cytokines and chemokines in HBV-associated HCC patients. However, effects of the HBx on autocrine chemokine expression profiles of hepatoma cells, which were shown in modulation of tumor-immune cell interactions, have not been investigated comprehensively. In the present study, human hepatoma cell lines SMMC-7721 and HepG2 were transfected with HBx-expressing plasmid. Human chemokine antibody array 1 (RayBio®), which simultaneously detects 38 chemokine factors, was used to determine chemokine expression profiles. Real-time polymerase chain reaction (real-time PCR) was used to further confirm the differential expression of chemokines. Chemokine antibody array revealed that all 38 chomekines were found to be expressed by SMMC-7721 and HepG2 cell lines. Interleukin-8 (IL-8) was obviously up-regulated, and epithelial neutrophil-activating protein 78 (ENA78), eosinophil chemotactic protein-1 (Eotaxin-1), monocyte chemotactic protein-1 (MCP-1), MCP-2, MCP-3 and macrophage inflammatory protein-3β (MIP-3β) were significantly declined in both cell lines following transfection of HBx-expressing plasmid. Other chemokines showed little or no significant changes. HBx-induced differential chemokine expression levels were validated by real-time PCR. Hierarchical cluster analysis identified a distinction of chomekine expression profiles between HBX-expressing hepatoma cell lines and controls. Our findings provide new evidence that HBx is able to selectively regulate chomekines in hepatoma cells that may be involved in the regulation of tumor-immune cell interactions.
Literatur
1.
Zurück zum Zitat Bosch FX, Ribes J, Diaz M, Cleries R (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127:S5–S16CrossRefPubMed Bosch FX, Ribes J, Diaz M, Cleries R (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127:S5–S16CrossRefPubMed
2.
Zurück zum Zitat Chen L, Zhao H, Yang X, Gao JY, Cheng J (2014) HBsAg-negative hepatitis B virus infection and hepatocellular carcinoma. Discov Med 18:189–193PubMed Chen L, Zhao H, Yang X, Gao JY, Cheng J (2014) HBsAg-negative hepatitis B virus infection and hepatocellular carcinoma. Discov Med 18:189–193PubMed
3.
4.
Zurück zum Zitat Almajhdi FN, Al-Qudari AY, Hussain Z (2013) Differential expression of transforming growth factor-β1 and HBx enhances hepatitis B virus replication and augments host immune cytokines and chemokines. Ann Hepatol 12:408–415PubMed Almajhdi FN, Al-Qudari AY, Hussain Z (2013) Differential expression of transforming growth factor-β1 and HBx enhances hepatitis B virus replication and augments host immune cytokines and chemokines. Ann Hepatol 12:408–415PubMed
5.
Zurück zum Zitat Cho HK, Kim SY, Seong JK, Cheong J (2014) Hepatitis B virus X increases immune cell recruitment by induction of chemokine SDF-1. FEBS Lett 588:733–739CrossRefPubMed Cho HK, Kim SY, Seong JK, Cheong J (2014) Hepatitis B virus X increases immune cell recruitment by induction of chemokine SDF-1. FEBS Lett 588:733–739CrossRefPubMed
6.
Zurück zum Zitat Johrer K, Pleyer L, Olivier A, Maizner E, Zelle-Rieser C, Greil R (2008) Tumour-immune cell interactions modulated by chemokines. Expert Opin Biol Ther 8:269–290CrossRefPubMed Johrer K, Pleyer L, Olivier A, Maizner E, Zelle-Rieser C, Greil R (2008) Tumour-immune cell interactions modulated by chemokines. Expert Opin Biol Ther 8:269–290CrossRefPubMed
7.
Zurück zum Zitat O’Hayre M, Salanga CL, Handel TM, Allen SJ (2008) Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J 409:635–649CrossRefPubMed O’Hayre M, Salanga CL, Handel TM, Allen SJ (2008) Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J 409:635–649CrossRefPubMed
8.
Zurück zum Zitat López-Lago MA, Posner S, Thodima VJ, Molina AM, Motzer RJ, Chaganti RS (2013) Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression. Oncogene 32:1752–1760CrossRefPubMedPubMedCentral López-Lago MA, Posner S, Thodima VJ, Molina AM, Motzer RJ, Chaganti RS (2013) Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression. Oncogene 32:1752–1760CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Roth MD, Harui A (2015) Human tumor infiltrating lymphocytes cooperatively regulate prostate tumor growth in a humanized mouse model. J Immunother Cancer 3:12CrossRefPubMedPubMedCentral Roth MD, Harui A (2015) Human tumor infiltrating lymphocytes cooperatively regulate prostate tumor growth in a humanized mouse model. J Immunother Cancer 3:12CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Verbeke H, Geboes K, Van Damme J, Struyf S (2012) The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer. Biochim Biophys Acta 1825:117–129PubMed Verbeke H, Geboes K, Van Damme J, Struyf S (2012) The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer. Biochim Biophys Acta 1825:117–129PubMed
11.
Zurück zum Zitat Ben-Baruch A (2006) The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev 25:357–371CrossRefPubMed Ben-Baruch A (2006) The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev 25:357–371CrossRefPubMed
12.
Zurück zum Zitat Park MH, Lee JS, Yoon JH (2012) High expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor-infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma. J Surg Oncol 106:386–392CrossRefPubMed Park MH, Lee JS, Yoon JH (2012) High expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor-infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma. J Surg Oncol 106:386–392CrossRefPubMed
13.
Zurück zum Zitat Hirano S, Iwashita Y, Sasaki A, Kai S, Ohta M, Kitano S (2007) Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes. J Gastroenterol Hepatol 22:690–696PubMed Hirano S, Iwashita Y, Sasaki A, Kai S, Ohta M, Kitano S (2007) Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes. J Gastroenterol Hepatol 22:690–696PubMed
14.
Zurück zum Zitat Pollicino T, Bellinghieri L, Restuccia A, Raffa G, Musolino C, Alibrandi A, et al. (2013) Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. Virology 444:317–328CrossRefPubMed Pollicino T, Bellinghieri L, Restuccia A, Raffa G, Musolino C, Alibrandi A, et al. (2013) Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. Virology 444:317–328CrossRefPubMed
15.
Zurück zum Zitat Chen HY, Tang NH, Li XJ, Zhang SJ, Chen ZX, Wang XZ (2004) Transfection and expression of hepatitis B virus x gene and its effect on apoptosis in HL-7702 cells. World J Gastroenterol 10:959–964PubMedPubMedCentral Chen HY, Tang NH, Li XJ, Zhang SJ, Chen ZX, Wang XZ (2004) Transfection and expression of hepatitis B virus x gene and its effect on apoptosis in HL-7702 cells. World J Gastroenterol 10:959–964PubMedPubMedCentral
16.
Zurück zum Zitat Luo MX, Wong SH, Chan MT, Yu L, Yu SS, Wu F, et al. (2015) Autophagy mediates HBx-induced nuclear factor-κB activation and release of IL-6, IL-8, and CXCL2 in hepatocytes. J Cell Physiol 230:2382–2389CrossRefPubMed Luo MX, Wong SH, Chan MT, Yu L, Yu SS, Wu F, et al. (2015) Autophagy mediates HBx-induced nuclear factor-κB activation and release of IL-6, IL-8, and CXCL2 in hepatocytes. J Cell Physiol 230:2382–2389CrossRefPubMed
17.
Zurück zum Zitat Sun LF, Shi C, Yuan L, Sun Y, Yao XX, Ma JW, et al. (2013) Expression of cytokines in mouse hepatitis B virus X gene-transfected model. J Huazhong Univ Sci Technolog Med Sci 33:172–177CrossRefPubMed Sun LF, Shi C, Yuan L, Sun Y, Yao XX, Ma JW, et al. (2013) Expression of cytokines in mouse hepatitis B virus X gene-transfected model. J Huazhong Univ Sci Technolog Med Sci 33:172–177CrossRefPubMed
18.
Zurück zum Zitat Han J, Yoo HY, Choi BH, Rho HM (2000) Selective transcriptional regulations in the human liver cell by hepatitis B viral X protein. Biochem Biophys Res Commun 272:525–530CrossRefPubMed Han J, Yoo HY, Choi BH, Rho HM (2000) Selective transcriptional regulations in the human liver cell by hepatitis B viral X protein. Biochem Biophys Res Commun 272:525–530CrossRefPubMed
19.
Zurück zum Zitat Miyagawa T, Sugaya M, Okada A, Asano Y, Kadono T, Sato S (2014) Neutrophil-rich anaplastic large cell lymphoma expressing interleukin-8. Acta Derm Venereol 94:741–742CrossRefPubMed Miyagawa T, Sugaya M, Okada A, Asano Y, Kadono T, Sato S (2014) Neutrophil-rich anaplastic large cell lymphoma expressing interleukin-8. Acta Derm Venereol 94:741–742CrossRefPubMed
20.
Zurück zum Zitat Cougot D, Wu Y, Cairo S, Caramel J, Renard CA, Lévy L, et al. (2007) The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription. J Biol Chem 282:4277–4287CrossRefPubMed Cougot D, Wu Y, Cairo S, Caramel J, Renard CA, Lévy L, et al. (2007) The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription. J Biol Chem 282:4277–4287CrossRefPubMed
22.
Zurück zum Zitat Li XP, Yang XY, Biskup E, Zhou J, Li HL, Wu YF, et al (2015) Co-expression of CXCL8 and HIF-1α is associated with metastasis and poor prognosis in hepatocellular carcinoma. Oncotarget 6:22880–22889 Li XP, Yang XY, Biskup E, Zhou J, Li HL, Wu YF, et al (2015) Co-expression of CXCL8 and HIF-1α is associated with metastasis and poor prognosis in hepatocellular carcinoma. Oncotarget 6:22880–22889
23.
Zurück zum Zitat Perez LE, Parquet N, Meads M, Anasetti C, Dalton W (2010) Bortezomib restores stroma-mediated APO2L/TRAIL apoptosis resistance in multiple myeloma. Eur J Haematol 84:212–222CrossRefPubMed Perez LE, Parquet N, Meads M, Anasetti C, Dalton W (2010) Bortezomib restores stroma-mediated APO2L/TRAIL apoptosis resistance in multiple myeloma. Eur J Haematol 84:212–222CrossRefPubMed
24.
Zurück zum Zitat Taub DD, Proost P, Murphy WJ, Anver M, Longo DL, van Damme J, et al. (1995) Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest 95:1370–1376CrossRefPubMedPubMedCentral Taub DD, Proost P, Murphy WJ, Anver M, Longo DL, van Damme J, et al. (1995) Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest 95:1370–1376CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Wang Q, Shu C, Su J, Li X (2015) A crosstalk triggered by hypoxia and maintained by MCP-1/miR-98/IL-6/p38 regulatory loop between human aortic smooth muscle cells and macrophages leads to aortic smooth muscle cells apoptosis via Stat1 activation. Int J Clin Exp Pathol 8:2670–2679PubMedPubMedCentral Wang Q, Shu C, Su J, Li X (2015) A crosstalk triggered by hypoxia and maintained by MCP-1/miR-98/IL-6/p38 regulatory loop between human aortic smooth muscle cells and macrophages leads to aortic smooth muscle cells apoptosis via Stat1 activation. Int J Clin Exp Pathol 8:2670–2679PubMedPubMedCentral
26.
Zurück zum Zitat Luo KQ, Shi YN, Peng JC (2014) The effect of chemokine CC motif ligand 19 on the proliferation and migration of hepatocellular carcinoma. Tumour Biol 35:12575–12581CrossRefPubMed Luo KQ, Shi YN, Peng JC (2014) The effect of chemokine CC motif ligand 19 on the proliferation and migration of hepatocellular carcinoma. Tumour Biol 35:12575–12581CrossRefPubMed
27.
Zurück zum Zitat Lu J, Ma J, Cai W, Wangpu X, Feng H, Zhao J, et al. (2015) CC motif chemokine ligand 19 suppressed colorectal cancer in vivo accompanied by an increase in IL-12 and IFN-γ. Biomed Pharmacother 69:374–379CrossRefPubMed Lu J, Ma J, Cai W, Wangpu X, Feng H, Zhao J, et al. (2015) CC motif chemokine ligand 19 suppressed colorectal cancer in vivo accompanied by an increase in IL-12 and IFN-γ. Biomed Pharmacother 69:374–379CrossRefPubMed
28.
Zurück zum Zitat Lotfi R, Lee JJ, Lotze MTJ (2007) Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors. J Immunother 30:16–28CrossRefPubMed Lotfi R, Lee JJ, Lotze MTJ (2007) Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors. J Immunother 30:16–28CrossRefPubMed
29.
Zurück zum Zitat Arenberg DA, Keane MP, DiGiovine B, Kunkel SL, Morris SB, Xue YY, et al. (1998) Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J Clin Invest 102:465–472CrossRefPubMedPubMedCentral Arenberg DA, Keane MP, DiGiovine B, Kunkel SL, Morris SB, Xue YY, et al. (1998) Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J Clin Invest 102:465–472CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Lim JB, Chung HW (2015) Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer. Cytokine 7:16–22CrossRef Lim JB, Chung HW (2015) Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer. Cytokine 7:16–22CrossRef
31.
Zurück zum Zitat Zhu F, Liu P, Li J, Zhang Y (2014) Eotaxin-1 promotes prostate cancer cell invasion via activation of the CCR3-ERK pathway and upregulation of MMP-3 expression. Oncol Rep 31:2049–2054PubMed Zhu F, Liu P, Li J, Zhang Y (2014) Eotaxin-1 promotes prostate cancer cell invasion via activation of the CCR3-ERK pathway and upregulation of MMP-3 expression. Oncol Rep 31:2049–2054PubMed
Metadaten
Titel
Chemokine Expression Profiles of Human Hepatoma Cell Lines Mediated by Hepatitis B Virus X Protein
verfasst von
Di-Yi Wang
Li-Ping Zou
Xiao-Jia Liu
Hong-Guang Zhu
Rong Zhu
Publikationsdatum
01.04.2016
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 2/2016
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-015-0014-9

Weitere Artikel der Ausgabe 2/2016

Pathology & Oncology Research 2/2016 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.